Another method for the differential analysis of EEG data of AD patients and healthy participants is 1 0 0 coherence analysis. Coherence refers to the functional connectivity of different brain regions and is 1 0 1 measured by the synchrony of oscillations recorded at different EEG electrodes. Earlier studies have 1 0 2 indicated that the coherence of EEG channels can help in the diagnosis of AD (28) (29) (30). These 1 0 3 studies showed that the reduction in the functional connectivity of the brain regions is captured as a 1 0 4 decrease in the coherence between EEG channels (31). Some reports have also assessed the relative value 1 0 5 of the coherence of EEG channels for different frequency bands in the classification of AD patients and 1 0 6 healthy participants (32) (33). 1 0 7
In this paper, we examine the characteristics of olfactory response as markers for the diagnosis of AD 1 0 8 through the use of both EEG and behavioral olfactory response data. Our EEG analysis comprises an 1 0 9 assessment of the statistical significance of the coherence in the EEG data across the spatial domain for 1 1 0 different frequency bands. In the behavioral olfactory response data, our approach identifies the best 1 1 1 subset of odorants among those in a localized version of the UPSIT kit (Iran-SIT (16)), which 1 1 2 significantly contributes to classifying AD patients from healthy participants. MMSE scores are also used 1 1 3 as reference for evaluating our olfactory-based results. Single-modality regressors are developed 1 1 4 employing the significant components identified in each set of olfactory response data (EEG coherence 1 1 5 and behavioral UPSIT) separately. The regressors are age-adjusted to account for the decline in the 1 1 6 performance caused by normal aging. Furthermore, by employing the statistically significant components 1 1 7 from both modalities, we propose a multi-modal classifier of AD patients versus healthy participants, 1 1 8 which also regresses the olfactory decline due to aging. 1 1 9 1 2 0 Figure 1 illustrates an overview of the multi-modal data analysis methodology used in our study. 1 2 1 1 2 2 Figure 1 . An overview of our methodology. The coherence between EEG electrode pairs in different 1 2 3 frequency bands, the modified Iran-SIT score, and the age of participants are used as features for training 1 2 4 an SVM classifier. The modification of the Iran-SIT score as well as the selection of significant frequency 1 2 5 bands and connections in the EEG records are carried out by statistical analysis. 1 2 6
Participants 1 2 7
This study was approved by the Review Board of Tehran University of Medical Sciences and all 1 2 8 participants gave their written consent to participate in the experiment. Participants were selected among 1 2 9 the individuals referring to the memory clinics of two hospitals in Tehran (Ziaeian Hospital and Roozbeh 1 3 0
Hospital, both affiliated with Tehran University of Medical Sciences) with memory performance 1 3 1 complaints. All the tests were carried out in the Department of Geriatric Medicine of Ziaeian Hospital in 1 3 2 South of Tehran. Two expert neuropsychologists assessed all the participants and recorded their smoking 1 3 3 history, preferred hand, age, level of education, as well as any past olfactory problem. Demographic and 1 3 4 medical history data were also collected for each participant. A total of 52 participants were recruited for 1 3 5
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Clinical Diagnostic Assessment
an area under the curve (AUC) of 0.87. These results suggest that there is a relationship between age, 2 8 0 olfactory functionality (represented by the UPSIT score) and the diagnosis of AD. 2 8 1 As shown in Figure 2a , the olfactory functionality decreases with age in both the AD and healthy groups. 2 8 2 However, the decline is more significant in the AD group and can be distinguished from the deficit caused 2 8 3 by normal aging. 2 8 4 2 8 5 Figure 2 . The total and modified UPSIT (Iran-SIT) scores plotted versus age: a) Total UPSIT score, b) 2 8 6
Modified UPSIT score. A regression line is fitted to the data of each group in both figures, and the 2 8 7 confidence bounds are also plotted.
8 8
As mentioned in the previous section, p-value was calculated for each odor to identify the most sensitive 2 8 9 odorants. Two significant odors (p-value < 0.05) were identified (Grape and Chocolate). These odors, as 2 9 0 well as their p-values, are shown in Table 3 We then calculated the modified UPSIT score for each participant by summing the responses to the two 2 9 4 sensitive odors. The resulting modified score versus age is plotted in Figure 2b . It can be seen that by 2 9 5 only using the two significant odors, the test can separate AD patients from healthy participants. 2 9 6
The MMSE and total UPSIT scores of AD patients and healthy participants are plotted versus age in a 2 9 7 three-dimensional plot in Figure 3a . It can be seen that the two groups are relatively separable. However, 2 9 8 there are still several data points that cannot be correctly classified.
9 9
In order to analyze whether our modifications can cause complete separability of the two groups, the 3 0 0 MMSE and Modified UPSIT scores are plotted versus age in Figure 3b . It can be seen that the two groups 3 0 1 are entirely separable when modified UPSIT scores are used. To analyze which odors can discriminate between AD patients and healthy participants and which odors 3 0 5 can still be perceived by AD patients, two visualizations of the UPSIT results are presented in Figure 4 . 3 0 6
The two significant odors (Grape and Chocolate) are indicated in both plots. In Figure 4a , the number of 3 0 7 AD patients and healthy participants who answered each UPSIT odor identification question correctly is 3 0 8 plotted. It can be seen that more than half of AD patients correctly identified the smells of Minty 3 0 9
Toothpaste, Jasmine, Pineapple, and Strawberry. Figure 4b shows the UPSIT results when the participants 3 1 0 in each group are divided into five-year age bins. patients who answered each question correctly. The x-axis denotes the tested odors and is sorted from the 3 1 5 left by the number of correct answers that the AD patients gave. Hence, the leftmost odor is the one that 3 1 6 the AD patients identified most. The y-axis is the number of correct answers to each odor identification 3 1 7 question. Two odors that are statistically significant in distinguishing between AD patients and healthy 3 1 8 participants are denoted by an asterisk and a triangle. b) The number of correct answers for each UPSIT 3 1 9 (Iran-SIT) odor identification question divided into five-year age bins. The shade of each bin denotes the 3 2 0 number of correct answers. Green (light) pixels indicate that most participants in the corresponding age 3 2 1 bin answered the question correctly, and the blue (dark) pixels suggest that most of the participants were 3 2 2 unable to identify the questioned odor. The upper diagram is for the healthy participants, and the lower 3 2 3 diagram is for the AD patients. The two statistically significant odors are denoted by dashed boxes. 3 2 4
EEG Coherence
The imaginary part of coherence between each pair of EEG electrodes was calculated for each of the 3 2 6 delta, theta, alpha, beta, and gamma frequency bands. To assess the significance of each of the six 3 2 7 connections in the analysis, the mean value of the imaginary part of coherence across all five frequency 3 2 8 bands was calculated for each connection. Statistical analysis indicated the imaginary part of coherence 3 2 9
between the Fz and Cz channels to possess the highest significance in separating the two groups of AD 3 3 0 patients and healthy participants. Figure 5a illustrates the relative significance of the six electrode-pair 3 3 1 connections. 3 3 2 Then, p-values were calculated for the value of coherence in each frequency band for each connection, 3 3 3 resulting in a total of 30 p-values (5 frequency bands times six connections). The Benjamini and 3 3 4
Hochberg correction was applied using the effective sample size (38) calculated based on the correlation 3 3 5 between the connections. This analysis resulted in the identification of the gamma (p-value = 0.005) and 3 3 6 beta (p-value = 0.015) bands of the Fz-Cz connection to be significant. These two coherence values were 3 3 7 selected as features for an SVM classifier of the two groups of participants. We classified the EEG coherence data of the AD patients and healthy participants using a regressor 3 4 6 combining the beta coherence, the gamma coherence and the age of participants. The results are shown in 3 4 7 
Multimodal Analysis
The significant components identified in the behavioral olfactory test (UPSIT) and the EEG coherence 3 5 2 analysis along with age were used as features to build an SVM classifier of AD patients and healthy 3 5 3 participants. The performance of this multi-modal classifier, as well as its comparison with single-3 5 4 modality classifier results, are shown in Table 4 . 3 5 5
The multi-modal classifier outperforms the single-modality classifiers in terms of accuracy. Besides, the 3 5 6 resulting data collection protocol only requires the participants to answer two questions in the UPSIT test 3 5 7 and the EEG data to be recorded from 3 electrodes (Fz, Cz, Fp1) and a reference (A1), offering a 3 5 8 convenient procedure for examining elderly participants. The accuracy of the proposed multi-modal 3 5 9
classifier is comparable to the MMSE-based classifier. 3 6 0 Discussion 3 6 1 Standard diagnosis methods for AD based on CSF analysis involve invasive sampling and are hence not 3 6 2 suitable for longitudinal studies (48). The proposed olfactory-based methodology in this paper is 3 6 3 convenient to conduct and has considerably lower costs. It is also more accommodating for elderly 3 6 4 patients as both the behavioral and EEG tests only require a small number of measurements. It hence 3 6 5 provides a viable solution for monitoring the progress of the disease in a patient over time, and offers 3 6 6 opportunities for longitudinal research studies. 3 6 7
In this study, we showed that the grape and chocolate odors could discriminate between AD patients and 3 6 8 healthy participants with fair accuracy. Earlier studies have assessed the ability of different scents in 3 6 9 similar tasks. For example, the study by Kjelvik et al.
(2) identified some significant odors, which 3 7 0 interestingly, chocolate was among them. A proposition for conducting olfactory-based studies would 3 7 1 hence be to perform experiments in culturally-diverse groups of populations and identify the marker odors 3 7 2 which are significant universally and those best suited for each culture or geography. 3 7 3
We also identified odors in our study which more than half of our AD patients could still perceive and 3 7 4 successfully recognize. Understandably, a survey of a larger population is needed to identify such odors 3 7 5 with more confidence. An interesting application for this set of scents would be to include them in 3 7 6 olfactory assessment tests to discriminate between AD patients and individuals with anosmia or non-AD 3 7 7 neurodegenerative diseases which can lead to the loss of olfactory functionality. 3 7 8
It should be noted that some odors could not be correctly identified by either of the healthy and AD 3 7 9 groups. A reason for this lack of performance by the healthy participants might be the unfamiliarity of the 3 8 0 study group with certain scents. For instance, both the AD and healthy groups were unable to identify the 3 8 1
Coca-Cola odor because most Iranian elderly may have not experienced this smell in their daily life. 3 8 2
These non-discriminating odors can be replaced in future sniffing kits by other scents to improve the 3 8 3 performance of the test. 3 8 4
The result of EEG-based olfactory assessment suggested that the coherence in the gamma and beta bands 3 8 5 significantly differ between AD patients and healthy participants. This result is in agreement with the 3 8 6 evidence about the roles that the gamma and beta bands play in cognitive functions of the brain, and their 3 8 7 deficit resulting from the neurodegenerative effects of AD. The high-frequency gamma oscillations (30-3 8 8 100 Hz) and the beta oscillations (13-30 Hz) appear to be particularly well suited for the maintenance of 3 8 9 functions in the brain that involve binding the processed data from different sensory modules or elements 3 9 0 stored in the memory (49). Multi-sensory data integration (50) (51), attentional sensory selection (52) (53) 3 9 1 (54), working memory association (55), and generation of long-term memory through associations 3 9 2 embedded as synaptic weight adaptation (56) (57), are all performed under the gamma and beta 3 9 3 oscillatory regimes in the neuronal populations involved (49). 3 9 4
Employing high-frequency oscillations in functions that involve intricate recruitment of content from 3 9 5 multiple sites in the brain is not a coincidental phenomenon; the resolution that high-frequency 3 9 6 oscillations offer in their phase allows for fine-tuned coding of relative arrival times and latencies 3 9 7 involved in accessing information and hence provides great input selectivity through high-precision 3 9 8 control of spike timing (49) (58) (59). 3 9 9
Desynchronized neural activity and disruption of gamma oscillations have been observed in both human 4 0 0 AD patients (60) (61) (62) (63) and the AD mouse models (64) (65) (66). As neuronal connectivity is 4 0 1 affected by the accumulation of amyloid-β in the extracellular space (67), larger inhibitory circuits 4 0 2 operating under high-frequency regimes turn into subpopulations that may produce these oscillations 4 0 3 without synchrony with each other. In (68) the deficit in coherence between oscillations measured by 4 0 4 EEG electrodes across the scalp in different frequency bands has been proposed as a diagnostic marker of 4 0 5 dementia caused by Alzheimer's disease. 4 0 6
While it is still a matter of debate whether these deficits in high-frequency oscillations are a consequence 4 0 7 of the underlying disease progression or that they indeed play a causal role in inducing more biological 4 0 8 changes that promote the disease (67), the deficit in the high-frequency oscillations can be associated on 4 0 9 the functional level with the lowered binding activity in the cortex, causing the known symptoms of AD 4 1 0 such as cognitive decline and dementia. Our study revealed the significance of the gamma and beta band 4 1 1 coherences in separating AD patients and healthy participants and showed the difference to be more 4 1 2 significant across the spatial range measured by the Fz and Cz electrodes. This is the scalp region close to 4 1 3 the cortical areas known to be involved in many cognitive functions. 4 1 4
Our study showed that the olfactory deficit could be a fairly accurate marker for AD when behavioral 4 1 5 assessment results are combined with the coherency results of the EEG recording. The accuracy of the 4 1 6
proposed multi-modal classifier is significantly above the chance level (91.7%). Even if we develop a 4 1 7 classifier based on the MMSE scores -which is based on tests that directly evaluate the participant's 4 1 8 memory and cognition -we may not always reach 100% accuracy. A common issue in performing the 4 1 9 MMSE test is that some of its questions require reading and writing skills and therefore, illiterate subjects 4 2 0 cannot get any scores from those parts. Also, running the test requires interaction between the participant 4 2 1 and the memory specialist, increasing the probability of introducing bias during the test. Unlike MMSE, 4 2 2 the proposed method in this study requires much less interaction and the behavioral olfactory assessment 4 2 3 (UPSIT) test can be carried out even by the participants themselves if they have the ability to read the 4 2 4 questions. 4 2 5
Limitations 4 2 6
We have demonstrated the suitability of our methodology in identifying AD patients in a limited study on 4 2 7 the Iranian population. The proposed method has to be applied to a bigger population in order to validate 4 2 8 the usefulness of olfactory-based biomarkers in the diagnosis of AD. In addition, large-cohort research is 4 2 9 needed to confirm the results, both in terms of validating the significance of the identified odors and 4 3 0 coherence features, as well as examining the outcome when patients suffering from non-AD dementia or 4 3 1 moderate and severe AD patients are also present in the study. 4 3 2
As odor perception is a culture-dependent phenomenon, the exact results derived in our study may not be 4 3 3 directly applicable to different populations. A more comprehensive study comprising of populations of 4 3 4 participants from different cultural backgrounds is needed to verify the validity of the proposed approach 4 3 5 in general, and the significance of the individual scents or other features used in our regressors and 4 3 6 classifiers in particular. 4 3 7
A related notable remark is that while the results of the smell identification test (UPSIT) may have strong 4 3 8 cultural dependencies, the EEG-based coherence analysis may prove to be a relatively more robust 4 3 9 procedure. This is due to the fact that higher-level functions of the brain are represented in the coherence 4 4 0 values measured in the EEG analysis, and some level of abstraction from the particular smells that are 4 4 1 perceived may be represented in these measurements.
2
Another limitation of the smell identification test is that successfully answering questions in it involves 4 4 3 both the perception of the presented odor as well as its recognition through a memory recall process. This 4 4 4
indicates an inherent ambiguity in this test between a lack of perception of the presented smell and failure 4 4 5
to identify the name of the odor which may have indeed been perceived. The EEG-based olfactory 4 4 6 assessment is advantageous in this aspect to the UPSIT test as it mainly focuses on the perception ability 4 4 7 and not the identification or naming functions. 4 4 8 Extensions 4 4 9
One interesting extension of this work is to repeat the EEG-based experiments using the two odors 4 5 0 (chocolate and grape) which were identified in the olfactory recognition task as significant and compare 4 5 1 the results of the coherence analysis with the current results. As these two odors best separate the two 4 5 2 groups of participants, it is interesting to see any gains their usage may provide to the single-modal EEG-4 5 3 based coherence results. 4 5 4
An essential extension to the EEG analysis is to examine other approaches, such as the difference 4 5 5 between the responses to the two odorants within each group of AD patients and healthy participants. 4 5 6
There are two possible ways to derive these differences. One is to repeat the current coherency-based 4 5 7 approach separately for each of the odorants. The other is to make the comparison directly in the temporal 4 5 8 domain of the recorded EEG data after artifact and noise removal. Possible advantages of these odorant-4 5 9 differential analyses may include the additional dimension that they provide as the difference in responses 4 6 0 to the two presented odors. To perform this extension, it is better to conduct the experiments with a 4 6 1 sequence of odors in which both the odorants are presented randomly with equal probability so the 4 6 2 number of epochs related to each odorant would be comparable. 4 6 3
Another possible domain for extending the EEG-based olfactory test is to repeat the experiment for each 4 6 4 participant in more than one session and use different pairs of odorants in each experiment. This allows 4 6 5 for studying the sensitivity map of each participant relative to different odors. Running an experiment 4 6 6 with more than two odorants presented by the same olfactometer is a possibility in this domain, but 4 6 7 requires modifications in the design of the olfactometer. 4 6 8
On the cohort design side, a necessary extension is to recall the participants for another round of 4 6 9 experiments after a period of six to twelve months and perform longitudinal analyses to study the 4 7 0 2 6 correlation between the olfactory decline and the progress of the AD in each patient. Another critical 4 7 1 extension that can further evaluate the specificity power of the proposed approach is to include a third 4 7 2 participant group consisting of non-AD MCI patients and examine the single-and multi-modal analyses 4 7 3 of the current study in discriminating the three groups from one another. These two latter extensions are 4 7 4
within the scope of our on-going data collection campaign. Any additional results achieved in each of 4 7 5 these extended studies will be provided in future reports. 4 7 6 Conclusions 4 7 7
In this paper, we have demonstrated the efficacy of an inexpensive methodology for evaluating the 4 7 8 olfactory deficit in the elderly population for being utilized as a marker of AD with fair accuracy. Our 4 7 9
proposed approach combines behavioral olfactory data with EEG measurements to yield an accurate 4 8 0 assessment of the participant's state. 
